Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections (DFI) With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis.

ClinicalTrials.gov ID: NCT00366249

Public ClinicalTrials.gov record NCT00366249. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 10:40 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Comparison Study of the Safety and Efficacy of a Once-Daily Dose of Tigecycline Versus Ertapenem for the Treatment of Foot Infections in Subjects With Diabetes

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study was to look at the safety and effectiveness of a once-daily dose of tigecycline compared to ertapenem for the treatment of diabetic foot infections. The co-primary efficacy endpoints were not met.

Study identification

NCT ID
NCT00366249
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
1,061 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2007 (Type not available)
Primary completion
Mar 2009 (Actual)
Completion
Mar 2009 (Actual)
Last update posted
Apr 28, 2010

2007 – 2009

United States locations

U.S. sites
26
U.S. states
12
U.S. cities
23
Facility City State ZIP Site status
Not listed Los Angeles California 90010 —
Not listed Los Angeles California 91342 —
Not listed Northridge California 91326 —
Not listed San Francisco California 94115 —
Not listed Sylmar California 91342 —
Not listed Torrance California 90502 —
Not listed Orlando Florida 32801 —
Not listed Orlando Florida 32806 —
Not listed Pensacola Florida 32501 —
Not listed West Palm Beach Florida 33407 —
Not listed Honolulu Hawaii 96814 —
Not listed Chicago Illinois 60637 —
Not listed Evanston Illinois 60201 —
Not listed North Chicago Illinois 60064 —
Not listed Springfield Illinois 62701 —
Not listed Springfield Illinois 62791 —
Not listed Baltimore Maryland 21224 —
Not listed Boston Massachusetts 02215 —
Not listed Somers Point New Jersey 08244 —
Not listed Winston-Salem North Carolina 27103 —
Not listed Lima Ohio 45801 —
Not listed Toledo Ohio 43614 —
Not listed West Reading Pennsylvania 19610 —
Not listed Columbia South Carolina 29203 —
Not listed Dallas Texas 75203 —
Not listed San Antonio Texas 78229 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 185 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00366249, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 28, 2010 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00366249 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →